Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hipp, S
Right arrow Articles by Decker, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hipp, S
Right arrow Articles by Decker, T
Haematologica, Vol 90, Issue 10, 1433-1434
Copyright © 2005 by Ferrata Storti Foundation

Comparative Study

Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells

S Hipp, I Ringshausen, M Oelsner, C Bogner, C Peschel, and T Decker

Mammalian target of rapamycin (mTOR) inhibitors represent a new class of potential anticancer agents. The mTOR inhibitor, rapamycin, inhibited proliferation in three mantle cell lymphoma (MCL) cell lines and reduced cyclin D3 expression while cyclin D1 levels remained unchanged. This finding was confirmed in cells from a MCL patient.


This article has been cited by other articles:


Home page
 BloodHome page
J. Dal Col, P. Zancai, L. Terrin, M. Guidoboni, M. Ponzoni, A. Pavan, M. Spina, S. Bergamin, S. Rizzo, U. Tirelli, et al.
Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
Blood, May 15, 2008; 111(10): 5142 - 5151.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. T. Abraham and J. J. Gibbons
The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy
Clin. Cancer Res., June 1, 2007; 13(11): 3109 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Leseux, S. M. Hamdi, T. al Saati, F. Capilla, C. Recher, G. Laurent, and C. Bezombes
Syk-dependent mTOR activation in follicular lymphoma cells
Blood, December 15, 2006; 108(13): 4156 - 4162.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Rudelius, S. Pittaluga, S. Nishizuka, T. H.-T. Pham, F. Fend, E. S. Jaffe, L. Quintanilla-Martinez, and M. Raffeld
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Blood, September 1, 2006; 108(5): 1668 - 1676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.